Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A
D. M. Wolf, R. Rokicka-Milewska, S. Lopaciuk, A. B. Skotnicki, A. Klukowska, P. Laguna, J. Windyga, R. Kotitschke, W. G. StruffVolume:
10
Year:
2004
Language:
english
Pages:
11
DOI:
10.1111/j.1365-2516.2004.00947.x
File:
PDF, 101 KB
english, 2004